Designing Logistics Strategies Across Clinical Phases to Balance Cost, Reliability, & Patient Risk

• Comparing high-touch, premium logistics models used in early-phase trials with more standardized approaches required for late-stage and commercial distribution
• Managing the trade-off between cost optimization and guaranteed delivery when each patient dose carries significant clinical and financial value
• Implementing contingency strategies including overproduction, reallocation, and backup routing to mitigate disruption
• Transitioning logistics models from bespoke to scalable while maintaining delivery performance

Speakers:

Thomas Birger Edén-Jensen

Vice President & Head of External Supply Management Radiopharmaceuticals

Bayer